Cardiac remodeling occurring in patients with end-stage heart failure due to ischemic cardiomyopathy is related to PPAR activity, whereby inactivation of PPARα and PPARγ would lead to an increase in the production of ET-1 and the presence of cardiac fibrosis [69]. This evidence concerns the gene PPARA and ischemic cardiomyopathy.